Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
5.74
-0.48 (-7.80%)
Oct 29, 2025, 4:00 PM EDT - Market closed
IMDX Revenue
Insight Molecular Diagnostics had revenue of $518.00K in the quarter ending June 30, 2025, with 398.08% growth. This brings the company's revenue in the last twelve months to $4.26M, up 316.13% year-over-year. In the year 2024, Insight Molecular Diagnostics had annual revenue of $1.88M with 25.15% growth.
Revenue (ttm)
$4.26M
Revenue Growth
+316.13%
P/S Ratio
32.47
Revenue / Employee
$86,878
Employees
49
Market Cap
164.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.88M | 378.00K | 25.15% |
| Dec 31, 2023 | 1.50M | 545.00K | 56.89% |
| Dec 31, 2022 | 958.00K | -1.24M | -56.41% |
| Dec 31, 2021 | 2.20M | 982.00K | 80.76% |
| Dec 31, 2020 | 1.22M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
IMDX News
- 16 days ago - iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch - GlobeNewsWire
- 23 days ago - iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset' with Novel Therapy and GraftAssure Monitoring - GlobeNewsWire
- 5 weeks ago - Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando - GlobeNewsWire
- 7 weeks ago - Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database - GlobeNewsWire
- 7 weeks ago - IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants - GlobeNewsWire
- 2 months ago - iMDx to Participate in NYC Investment Conferences September 8 - 11 - GlobeNewsWire
- 2 months ago - IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch - GlobeNewsWire
- 3 months ago - iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference - GlobeNewsWire